Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7222
Delayed Data
As of Mar 26
 -0.0078 / -1.07%
Today’s Change
0.65
Today|||52-Week Range
1.29
+3.17%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Rexahn Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 1.25. The median estimate represents a +315.40% increase from the last price of 0.72.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Rexahn Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.03
Sales
$0.00
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -166.70%
 
 
 
 
 
 
Growthannually -4.55%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account